A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF
NCT05251467 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2024-07-22
Summary
Development of a new patient reported outcome measure (PROM) that will measure the daily burden of gastrointestinal symptoms over the previous 24 hour period for people with cystic fibrosis.
Conditions
- Cystic Fibrosis
- Digestive System Disease
- Genetic Disease
- Respiratory Tract Diseases
- Lung Diseases
- Pancreatic Disease
Interventions
- OTHER
-
Focus group
Focus group to confirm PROM conceptual framework
- OTHER
-
Patient interview (n = approximately 10)
Patient interviews to refine possible questions for the PROM
- OTHER
-
Questionnaire (n = 180)
Online questionnaire to evaluate the proposed questions as part of PROM development in a larger population
- DEVICE
-
Testing of the pilot PROM in a smartphone app (n = 150)
Daily testing of the pilot PROM in a smartphone app for 2 weeks
Sponsors & Collaborators
-
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Manchester University NHS Foundation Trust
collaborator OTHER_GOV -
Royal Brompton & Harefield NHS Foundation Trust
collaborator OTHER -
King's College Hospital NHS Trust
collaborator OTHER -
Medizinische Hochschule Brandenburg Theodor Fontane
collaborator OTHER -
Nottingham University Hospitals NHS Trust
lead OTHER
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-28
- Primary Completion
- 2023-12-03
- Completion
- 2023-12-03
Countries
- United Kingdom
Study Locations
More Related Trials
-
Gastroparesis in Cystic Fibrosis
NCT05223881 ·Status: WITHDRAWN ·Phase: NA
-
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
NCT03566550 ·Status: COMPLETED
-
A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function
NCT04038047 ·Status: COMPLETED
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Hormonal Responses to a Mixed Meal in People With Cystic Fibrosis
NCT06163482 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Gut Imaging for Function & Transit in Cystic Fibrosis Study 2
NCT04006873 ·Status: COMPLETED ·Phase: PHASE2
-
Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
NCT00485082 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Developing e-Health Systems to Improve Growth and Nutrition in CF
NCT03635762 ·Status: COMPLETED ·Phase: NA
-
Small Intestinal Function in Patients With Cystic Fibrosis
NCT01468428 ·Status: UNKNOWN
-
Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CF
NCT02464267 ·Status: COMPLETED
-
Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF)
NCT05526027 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis
NCT03801993 ·Status: COMPLETED
-
Technology-enabled Patient Support System for Self-management of CF
NCT03910881 ·Status: COMPLETED ·Phase: NA
-
A CFit Study - Acute Exercise
NCT03237767 ·Status: TERMINATED ·Phase: NA
-
Pilot Study of a CF-specific CBT Intervention for Adolescents
NCT05271643 ·Status: COMPLETED ·Phase: NA
-
The PROMISE Pediatric Study 6 to 11 Years Old
NCT04613128 ·Status: COMPLETED
-
Longitudinal Analysis of Respiratory and Intestinal Microbiome in Cystic Fibrosis
NCT03335202 ·Status: UNKNOWN
-
Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis
NCT03450720 ·Status: COMPLETED ·Phase: PHASE1
-
Near Patient Microbial Testing in Cystic Fibrosis
NCT01877707 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Behavioural Intervention Using App Technology in CF
NCT03782909 ·Status: COMPLETED ·Phase: NA
-
Perceptions of the CF Screening Protocol Incorporating NGS
NCT06299566 ·Status: COMPLETED
-
Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.
NCT03589313 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical Management
NCT04277819 ·Status: COMPLETED